Large animal model of vein grafts intimal hyperplasia: A systematic review.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
07 2023
Historique:
medline: 14 6 2023
pubmed: 29 5 2022
entrez: 28 5 2022
Statut: ppublish

Résumé

Coronary artery bypass grafting remains the treatment of choice for a large cohort of patients with significant coronary disease. Despite the increased use of arterial grafts, the long saphenous vein remains the most commonly used conduit. Long-term graft patency continues to be the Achilles heel of saphenous vein grafts. This is due to the development of intimal hyperplasia, a chronic inflammatory disease that results in the narrowing and occlusion of a significant number of vein grafts. Research models for intimal hyperplasia are essential for a better understanding of pathophysiological processes of this condition. Large animal models resemble human anatomical structures and have been used as a surrogate to study disease development and prevention over the years. In this paper, we systematically review all published studies that utilized large animal models of vein graft disease with a focus on the type of model and any therapeutic intervention, specifically the use of external stents/mesh.

Identifiants

pubmed: 35624557
doi: 10.1177/02676591221091200
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-930

Auteurs

Oluwatomini Fashina (O)

Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

Riccardo G Abbasciano (RG)

Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

Liam W McQueen (LW)

Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

Shameem Ladak (S)

Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

Sarah J George (SJ)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.

Sadeeh Suleiman (S)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.

Prakash P Punjabi (PP)

Department of Cardiovascular Sciences, Imperial College, Hammersmith Hospital, London, UK.

Gianni D Angelini (GD)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.

Mustafa Zakkar (M)

Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH